Schwab Impervious To A Bank Run? CEO Says Firm Is 100% Insulated If Depositors Flee
On the day after U.S.
Raymond James Financial Q1 EPS $2.29 Beats $2.28 Estimate, Sales $2.79B Miss $2.84B Estimate
Raymond James Financial (NYSE:RJF) reported quarterly earnings of $2.29 per share which beat the analyst consensus estimate of $2.28 by 0.44 percent. This is a 8.02 percent increase over earnings of $2.12 per share from
Headwinds Including Peak NII, Higher Beta Sensitivity, Slower NNA Forces Analyst To Double Downgrade Morgan Stanley
Wolfe Research analyst Steven Chubak downgraded Morgan Stanley (NYSE: MS) from Outperform to Un
Goldman Sachs’ Four Zones Within Capital Market Coverage, Gives Stock Picks
Goldman Sachs Group Inc (NYSE: GS) has outlined four themes for 2023 amid recessionary risks and rising interest rates.
Goldman Sachs Maintains Buy on Raymond James Finl, Lowers Price Target to $125
Goldman Sachs analyst Alexander Blostein maintains Raymond James Finl (NYSE:RJF) with a Buy and lowers the price target from $148 to $125.
Raymond James Financial Raises Quarterly Dividend From $0.34/Share To $0.42/Share; Co. Authorizes $1.5B Share Repurchase To Replace Previously Authorized $1B Program
On December 1, 2022, the Raymond James Financial, Inc. (NYSE:RJF) Board of Directors declared a quarterly cash dividend on shares of its common stock of $0.42 per share, payable January 17, 2023 to shareholders
Expert Ratings for Raymond James Financial
Raymond James Financial (NYSE:RJF) has observed the following analyst ratings within the last quarter:
Caterpillar, Greenbrier, ServiceNow And Other Big Gainers From Thursday
U.S. stocks closed mixed on Thursday, with the Dow Jones gaining close to 200 points. Here is the list of some big stocks recording gains in the previous session.
Credit Suisse Initiates Coverage On Raymond James Financial with Neutral Rating, Announces Price Target of $120
Credit Suisse analyst William Katz initiates coverage on Raymond James Financial (NYSE:RJF) with a Neutral rating and announces Price Target of $120.
3 Analysts Provide Takeaways From Walgreens’ Upbeat Results
Walgreens Boots Alliance Inc. (NASDAQ: WBA) swung to a loss in the third quarter but managed to beat Street expectations.